High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial von BEZWODA, W. R, SEYMOUR, L, DANSEY, R. D

Volltext

High-dose chemotherapy and CD34-selected peripheral blood progenitor cell transplantation for patients with breast cancer metastatic to bone and/or bone marrow von KLEIN, J. L, HAMM, C, DANSEY, R. D, KARANES, C, ABELLA, E, CASSELLS, L, PETERS, W. P, BAYNES, R. D

Volltext

Cardiac sequelae of doxorubicin and paclitaxel as induction chemotherapy prior to high-dose chemotherapy and peripheral blood progenitor cell transplantation in women with high-ris... von Klein, J L, Rey, P M, Dansey, R D, Karanes, C, Du, W, Abella, E, Cassells, L, Hamm, C, Peters, W P, Baynes, R D

Volltext

Single high-dose etoposide and melphalan with non-cryopreserved autologous marrow rescue as primary therapy for relapsed, refractory and poor-prognosis Hodgkin's disease von SEYMOUR, L. K, DANSEY, R. D, BEZWODA, W. R

Volltext

High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Breast Cancer von Baynes, Roy D., Dansey, Roger D., Klein, Jared L., Karanes, Chatchada, Cassells, Lucinda, Abella, Esteban, Wei, Wei-Zen, Galy, Anne, Du, Wei, Wood, Gary, Peters, William P.

Volltext

Lack of a significant independent effect of race on survival in breast cancer von Dansey, R. D., Hessel, P. A., Browde, S., Lange, M., Derman, D., Nissenbaum, M., Bezwoda, W. R.

Volltext

Nonablative allogeneic hematopoietic stem cell transplantation von Dansey, Roger D, Baynes, Roy D

Volltext

Seizures and neurocysticercosis in black men von DANSEY, R. D, HAY, M, COWIE, R. L

Volltext

Comparison of cefotaxime with ceftriaxone given intramuscularly 12-hourly for community-acquired pneumonia von Dansey, Roger D., Jacka, Peter J., Strachan, Simon A., Hay, Malcolm

Volltext

Captopril in hypertensive black men in southern Africa von COWIE, R. L, DANSEY, R. D

Volltext

DEEP-VEIN THROMBOSIS AND PULMONARY TUBERCULOSIS von Cowie, R.L., Dansey, R.D., Hay, M.

Volltext

Effect of denosumab versus zoledronic acid on health-related quality of life in patients with metastatic breast cancer von Fallowfield, L., Patrick, D., Body, J., Lipton, A., Tonkin, K. S., Qian, Y., Jiang, Q., Braun, A. H., Dansey, R. D., Chung, K.

Volltext

A randomized, double-blind, placebo-controlled multicenter phase III study comparing denosumab with placebo as adjuvant treatment for women with early-stage breast cancer who are a... von Goss, P. E., Barrios, C. H., Bell, R., Finkelstein, D., Iwata, H., Martin, M., Braun, A. H., Dansey, R. D., Coleman, R. E.

Volltext

Effects of denosumab versus zoledronic acid (ZA) on pain in patients (pts) with advanced cancer (excluding breast and prostate) or multiple myeloma (MM): Results from a randomized... von von Moos, R., Patrick, D., Fallowfield, L., Cleeland, C. S., Henry, D. H., Qian, Y., Dansey, R. D., Chung, K.

Volltext

Effects of denosumab versus zoledronic acid (ZA) on health-related quality of life (HRQL) in metastatic breast cancer: Results from a randomized phase III trial von Fallowfield, L., Patrick, D., Body, J., Lipton, A., Tonkin, K. S., Qian, Y., Jiang, Q., Dansey, R. D., Chung, K.

Volltext

A randomized phase III trial of denosumab versus zoledronic acid in patients with bone metastases from castration-resistant prostate cancer von Fizazi, K., Carducci, M. A., Smith, M. R., Damião, R., Brown, J. E., Karsh, L., Milecki, P., Wang, H., Dansey, R. D., Goessl, C. D.

Volltext

Delaying skeletal-related events in a randomized phase III study of denosumab versus zoledronic acid in patients with advanced cancer von Henry, D. H., von Moos, R., Hungria, V., Costa, L., Woll, P. J., Scagliotti, G., Wang, J., Jun, S., Dansey, R. D., Yeh, H.

Volltext

Denosumab in the treatment of bone metastases from advanced cancer or multiple myeloma (MM): Analyses from a phase III randomized trial von Vadhan-Raj, S., Henry, D. H., von Moos, R., Hungria, V., Goldwasser, F., Scagliotti, G., Wang, J., Jun, S., Dansey, R. D., Yeh, H.

Volltext

A meta-analysis of results from two randomized, double-blind studies of denosumab versus zoledronic acid (ZA) for treatment of bone metastases von Lipton, A., Stopeck, A., von Moos, R., Henry, D. H., Richardson, G. E., Rodriguez, G. I., Bourgeois, H. P., Ke, C., Jun, S., Dansey, R. D.

Volltext

Effects of denosumab versus zoledronic acid (ZA) on pain in patients (pts) with metastatic breast cancer: Results from a phase III clinical trial von Stopeck, A., Fallowfield, L., Patrick, D., Cleeland, C. S., De Boer, R. H., Steger, G. G., Qian, Y., Jiang, Q., Dansey, R. D., Chung, K.

Volltext